Decision Support for drug
and device development
under uncertainty.

Bruno is a recognized leader in applied statistics with over 30 years of experience across pharmaceutical and medical device development. He has held senior roles at Eli Lilly and UCB, founded Arlenda in 2003, published over 100 scientific papers, and launched the BAYES conference series.

Arnaud is a Bayesian biostatistician with over 10 years in pharma, specializing in innovative statistical methodologies for clinical and CMC development. He serves on the BAYES Scientific Committee and is President of the Quetelet Society, advancing causal inference and Bayesian networks in life sciences.

Sophie is CEO of Trilenda — Esylos, Sanaitio & Arlenda. She brings over 30 years of international experience in regulatory consulting and operations, building and scaling organizations in complex regulated environments.

Nils leads technical architecture and AI-driven decision support at Esylos. With a Master's in Data Science Engineering, he brings expertise in machine learning, healthcare AI, and causal inference, with a focus on robust data infrastructure and patient-centric solutions.

20+ years in QA leadership. QMS aligned with GMP, GCP, GAMP5, ISO 9001/13485. Computerized system validation and complex GxP projects.

Cédric is the lead developer behind Arlenda's SmartSTATS platform, with nearly two decades of experience across banking, insurance, and pharmaceutical services. He has built and maintained the platform since 2010, covering Java development, web technologies, cloud infrastructure, containerization, database management, and Linux administration. He has kept SmartSTATS running, secure, and evolving for the past fifteen years.